Technical Analysis of Credit Allocation Mechanisms under the Minnesota Research and Development Tax Credit Framework
Allocating the credit within the Minnesota Research and Development (R&D) tax credit framework refers to the legal distribution of earned tax offsets from a generating entity to its constituent owners or affiliated unitary group members. This mechanism ensures that tax benefits derived from qualified innovation are effectively utilized across complex organizational structures, preventing the stranding of credits within entities lacking sufficient tax liability.1
The operational complexity of “allocating the credit” serves as the primary interface between the technical performance of research activities and the practical realization of fiscal incentives in the State of Minnesota. For pass-through entities, such as partnerships and S corporations, allocation dictates the pro-rata movement of credits to individual or corporate tax returns via specific state-mandated schedules like KPI or KS, adhering strictly to federal methodologies as modified by state boundaries.2 In the corporate sphere, particularly following the pivotal regulatory updates of June 2020, the concept of allocation has expanded to encompass the sharing of both current-year credits and carryforwards among members of a unitary business group.3 This evolution reflects a broader policy shift toward treating a combined reporting group as a single economic taxpayer, thereby optimizing the utilization of incentives for innovation performed exclusively within the state. The legal foundation for this process is found in Minnesota Statutes section 290.068, which integrates federal definitions from Internal Revenue Code (IRC) Section 41 while asserting specific local limitations on geographic nexus and calculation methodologies.1
Statutory Foundation and Legal Evolution of the Minnesota Research Credit
The Minnesota Credit for Increasing Research Activities, commonly known as the R&D tax credit, was established by the 1981 Legislature as a strategic response to the federal government’s adoption of similar incentives under the Economic Recovery Tax Act of 1981.5 From its inception, the credit was designed to mirror the federal structure, yet it has evolved through four decades of legislative and judicial refinement into a distinct state-specific instrument. The core intent of the credit, though not always explicitly stated in the statutes, has been interpreted by the Office of the Legislative Auditor as a tripartite effort to create or retain high-paying jobs, increase the volume of research activity within the state, and attract or retain innovative businesses in a competitive national landscape.5
The statutory language of section 290.068 serves as the bedrock for all allocation activities. It specifies that corporations, partners in partnerships, and shareholders in S corporations are eligible for a credit against the tax computed under Chapter 290.1 This eligibility is contingent upon the performance of “qualified research,” which Minnesota law defines by explicit reference to IRC Section 41(d), with one critical exception: the research must be conducted entirely within the state of Minnesota.4 This geographic restriction is the most significant hurdle for multistate entities and necessitates a precise “allocation” of expenses and credits to the Minnesota nexus before any further distribution to owners or group members can occur.8
The Tiered Rate Structure and the Incremental Method
Unlike the federal R&D credit, which typically offers a flat rate on incremental spending, Minnesota employs a tiered rate structure designed to maximize the benefit for smaller increments of research while still providing meaningful support for large-scale industrial projects.2 The current calculation utilizes two distinct rates applied to the “excess” of qualified research expenses over a calculated base amount.1
| Expense Tier | Applicable Credit Rate |
| First $2,000,000 of Excess Minnesota QREs | 10.0% |
| All Excess Minnesota QREs above $2,000,000 | 4.0% |
The calculation formula for the total credit $C$ can be formally expressed using the following notation, where $E$ represents the excess of current-year Minnesota qualified research expenses ($Q_{MN}$) over the Minnesota base amount ($B_{MN}$):
$$E = \max(0, Q_{MN} – B_{MN})$$
$$C = \begin{cases} 0.10 \times E & \text{if } E \leq 2,000,000 \\ (0.10 \times 2,000,000) + 0.04 \times (E – 2,000,000) & \text{if } E > 2,000,000 \end{cases}$$
This tiered structure creates a higher marginal incentive for the first $2 million of increased research spending, which disproportionately benefits medium-sized enterprises and focused innovation projects within larger firms.6 For many taxpayers, particularly those in the manufacturing and software sectors, the effective credit rate is a blend of these two tiers, requiring careful allocation planning to ensure that the maximum 10% benefit is utilized across the enterprise.6
Defining the Minnesota Base Amount
The concept of “allocating the credit” begins with the determination of the base amount, which acts as a threshold above which research spending becomes eligible for the incentive.1 Minnesota law incorporates the federal definition of “base amount” found in IRC Section 41(c), but it mandates that the variables in the equation—specifically gross receipts and qualified research expenses—be restricted to those originating in Minnesota.1
The base amount is generally the product of the taxpayer’s “fixed-base percentage” and the average annual gross receipts for the four preceding years.1 However, the law provides a critical “minimum base amount” rule: the base amount cannot be less than 50% of the current year’s qualified research expenses.1 For many Minnesota-based multistate businesses, this 50% limit is the actual determining factor in their credit calculation, as their Minnesota research often relates to global operations while their Minnesota gross receipts (the denominator in the fixed-base percentage calculation) remain relatively small.8
This dynamic was further clarified by the Minnesota Tax Court in cases such as General Mills, Inc. v. Commissioner of Revenue and International Business Machines Corporation v. Commissioner of Revenue.12 The court held that while qualified research expenditures are limited to Minnesota amounts, the “base amount” must be computed using federal gross receipts in certain parts of the denominator of the fixed-base percentage, creating a complex interplay between state and federal data points.12 This necessitates that tax professionals not only “allocate” credits but also perform deep analytical “allocations” of gross receipts to ensure compliance with judicial interpretations of the base amount formula.12
Mechanics of Allocation in Pass-Through Entities
For a significant portion of the Minnesota business community, research and development are conducted through “pass-through” structures, including S corporations, partnerships, and LLCs treated as partnerships.5 In these instances, “allocating the credit” is the legal act of moving the tax benefit from the entity that incurred the expense to the individuals or corporations that pay the income tax.2
Distribution Rules for Partnerships and LLCs
In the context of partnerships, Minnesota Statutes section 290.068 directs that the credit shall be allocated among the partners in the same manner as provided by Section 41(f)(2) of the Internal Revenue Code.2 This generally means that the credit follows the partner’s distributive share of the partnership’s income or loss for the taxable year.2
The operational guidance from the Minnesota Department of Revenue requires the partnership to complete Schedule RD (Credit for Increasing Research Activities) to calculate the total credit generated at the entity level.4 Once the total credit is determined, it is allocated to the partners. For individual partners, the credit amount is reported on Schedule KPI (Partner’s Share of Income, Credits and Modifications), specifically on the line designated for “Credit for Increasing Research Activities”.2 For corporate partners, the amount is reported on Schedule KPC.13
It is important to note that the allocation must be pro-rata based on the partner’s interest in the partnership unless a special allocation is permitted under both federal and state law.2 However, Minnesota guidance specifically notes that partners who elect to file composite returns are generally not entitled to receive this credit, as the credit must be claimed on the individual partner’s return to offset their specific Minnesota tax liability.13
Pro-Rata Allocation for S Corporations
The allocation mechanism for S corporations is slightly more rigid than that for partnerships. Under Minnesota law, the credit must be allocated to shareholders in the same manner as provided by IRC Section 1366(a), which requires a per-share, per-day pro-rata distribution.2 This ensures that the credit is distributed fairly based on ownership duration and percentage during the tax year in which the research expenses were incurred.
Shareholders receive their allocated portion of the credit on Schedule KS (Shareholder’s Share of Income, Credits and Modifications).2 When filing their individual income tax returns (Form M1), shareholders must include a copy of the Schedule KS and complete Schedule M1C (Other Nonrefundable Credits) to apply the credit against their tax liability.2 This process effectively “allocates” the state’s financial incentive for innovation directly into the pockets of the business owners, providing the necessary capital to reinvest in further research.5
Allocation within Unitary Business Groups: The 2020 Paradigm Shift
Perhaps the most complex and strategically significant form of “allocating the credit” occurs within unitary business groups—collections of related corporations that operate as a single economic unit for tax purposes.1 For these groups, allocation refers to the “sharing” of credits among different corporate members to ensure that the group’s total tax liability is minimized.2
Historical Context and the June 2020 Regulatory Change
Before 2020, the Minnesota Department of Revenue maintained a restrictive stance on the allocation of R&D credit carryforwards.2 While the law allowed the sharing of credits in the year they were generated, MDOR instructions previously suggested that any unused credit (a carryforward) was “trapped” at the specific corporate entity that originally earned it.2 This meant that if a research-heavy subsidiary had no tax liability in Year 2, it could not “allocate” its Year 1 carryforward to a profitable sister subsidiary within the same unitary group.
On June 17, 2020, following significant internal review and potentially in response to taxpayer challenges, the Minnesota Department of Revenue issued updated guidance that fundamentally changed this landscape.2 The new guidance clarified that for tax years beginning after December 31, 2012, the R&D credit carryover can be applied to other members of the combined group in the same manner that the credit is applied in the year of generation.2 This update was effective retroactively for all open tax years within the statute of limitations, which in Minnesota is generally 3.5 years.3
The Order of Operations for Unitary Allocation
The current MDOR guidance establishes a clear hierarchy for “allocating the credit” within a unitary business group to ensure that the earning member is prioritized while still allowing for group-wide efficiency.2
- Utilization by the Earning Member: In the year the credit is generated, the credit must first be used by the earning member to reduce its own tax liability to zero.2
- Current-Year Sharing: If any credit remains after the earning member’s liability is exhausted, the unused portion is allocated to other members of the combined group up to the amount of their respective tax liabilities.2
- Carryforward Generation: Any credit still remaining after group-wide allocation becomes a carryforward. This carryforward is initially held by the earning member.2
- Utilization of Carryforwards: In subsequent years, the earning member must first apply its own carryforward against its own tax liability. If a surplus remains, that carryforward can then be allocated to other group members.2
This “sharing” mechanism is reported on Schedule RD and reflected in the combined report (Form M4T). Specifically, the amount allocated to other members is entered on designated lines (such as Line 34 for current year and Line 44 for carryovers) and distributed among the group members’ columns on the tax return.13 This systemic allocation ensures that no portion of the R&D credit is wasted simply because of the internal corporate structure of the unitary group.3
Case Study: Unitary Allocation in a High-Tech Manufacturing Group
To illustrate the profound impact of these allocation rules, consider the following example of a Minnesota-based unitary group, “NorthStar Innovation Group,” during the 2024 tax year.
Entity Profiles and Initial Positions
NorthStar Innovation Group consists of three distinct corporate entities that file a combined Minnesota return:
- Alpha Corp (The Earning Member): Conducts advanced materials research in a lab in St. Paul. In 2024, Alpha Corp incurred $5,000,000 in Minnesota QREs. Its specific tax liability before credits is $50,000.
- Beta Corp (The Manufacturing Member): Handles the commercial production of Alpha’s designs. It has no R&D expenses but has a significant tax liability of $250,000.
- Gamma Corp (The Holding Member): Owns the group’s intellectual property and real estate. It has a tax liability of $10,000.
Step 1: Credit Calculation
Assuming a base amount of $2,000,000, Alpha Corp calculates its 2024 R&D credit on Schedule RD:
- Total Excess QREs: $5,000,000 – $2,000,000 = $3,000,000.
- First Tier Credit (10% of first $2M): $200,000.
- Second Tier Credit (4% of remaining $1M): $40,000.
- Total Generated Credit: $240,000.
Step 2: The Allocation Process
The group follows the MDOR order of operations to “allocate the credit”:
- Alpha Corp Utilization: Alpha uses $50,000 of its generated credit to reduce its own tax liability to zero.
- Allocation to Beta Corp: Alpha has $190,000 in unused credit. It allocates the full $190,000 to Beta Corp. Beta Corp applies this against its $250,000 liability, reducing it to $60,000.
- Allocation to Gamma Corp: Alpha’s 2024 credit is now exhausted. If Alpha had more credit, it would have allocated $10,000 to Gamma Corp.
Outcome and Strategic Value
Because of the ability to “allocate the credit” among group members, NorthStar Innovation Group reduced its total tax bill by $240,000 in the current year. Without this mechanism—if the credit were restricted to the earning member—the group would have only saved $50,000 in 2024 and been forced to carry forward $190,000 to future years, losing the time value of that capital.2 This example demonstrates how the 2020 guidance update facilitates immediate liquidity for groups that separate their research and production functions into different legal entities.3
The Future of Allocation: Partial Refundability starting in 2025
A landmark change in the Minnesota tax landscape was enacted in June 2025 with the passage of H.F. 9, which introduces partial refundability for the Credit for Increasing Research Activities.4 This legislation adds an entirely new dimension to the concept of “allocating the credit,” particularly for taxpayers with more credits than they can utilize through standard tax offsets.
The Refundability Rates and Election Process
Effective for tax years beginning after December 31, 2024, taxpayers can now elect to treat a portion of their unused research credit as a refundable credit.4 This means that instead of “allocating” the credit into a carryforward for use in future years, the taxpayer can receive a cash payment from the state.
| Taxable Year Beginning During | Refundability Rate of Unused Credit |
| 2025 | 19.2% |
| 2026 and 2027 | 25.0% |
| 2028 and later | The lesser of 25% or a rate set by the Commissioner |
Data source: Minnesota Statutes 290.068 as amended by H.F. 9.9
The “refundability rate” for years after 2027 is subject to an annual adjustment to ensure that total statewide refunds do not exceed approximately $25 million per year.9 This reflects the state’s cautious approach to fiscal management while still providing a significant boost to the cash positions of innovative firms.9
Implications for Allocation in Pass-Through Entities
The introduction of refundability creates a unique challenge for pass-through entities. According to MDOR guidance, the election for refundability is made by the individual partners, members, or shareholders, rather than at the entity level.4 This means that when a partnership “allocates the credit” to ten different partners, each partner independently decides whether to claim their share as a non-refundable offset (with a 15-year carryforward) or to elect the immediate 19.2% or 25% refund.4
This decentralized election process requires meticulous coordination. The partnership must still calculate the total credit on Schedule RD and allocate it via Schedule KPI or KS, but the individual taxpayer must then perform a separate calculation on their own return to determine the “refundable portion” after all other credits have reduced their liability to zero.4 For startups and biotech firms that are often organized as pass-throughs and have little to no tax liability, this new allocation option is expected to provide millions of dollars in immediate liquidity to fuel continued R&D.9
Statistical Insights and Economic Significance
The importance of the R&D credit and its allocation mechanisms is underscored by the scale of its utilization in the Minnesota economy. According to reports from the Minnesota Department of Revenue Tax Research Division and the Office of the Legislative Auditor, the credit is a primary driver of state tax policy in the technology and manufacturing sectors.5
Claim Trends and Corporate Dominance
Historical data indicates that while the number of pass-through claimants has increased, large C corporations continue to receive the lion’s share of the total credit value.5
| Year | Total Research Credits Claimed | C Corporation Share | Pass-Through Share |
| 2014 | $50 Million | 67% | 33% |
| 2010-2014 (Avg) | – | 81% | 19% |
Data compiled from OLA Evaluation Reports.5
The concentration of the credit is also notable. In the period from 2010 to 2014, the largest 20% of C corporations (measured by national sales) received two-thirds of the total tax credits claimed by all C corporations in Minnesota.5 This suggests that the “allocation” rules within large unitary groups are particularly consequential for the state’s fiscal balance, as these large entities are most likely to have the sophisticated corporate structures that benefit from the 2020 sharing rules.3
Industry Distribution
The manufacturing sector remains the dominant beneficiary of the credit, largely due to the high volume of qualified research conducted in traditional Minnesota strongholds such as medical devices, chemicals, and industrial equipment.5
| Industry Sector | Share of C-Corp R&D Credits |
| Manufacturing | 65% |
| Professional, Scientific, & Technical Services | 15% |
| Information / Software | 10% |
| Other Sectors | 10% |
Data source: 2017 Legislative Auditor Report.6
For these manufacturers, the ability to allocate credits between a specialized R&D subsidiary and a separate sales or manufacturing entity is essential for maintaining the competitiveness of Minnesota operations compared to other states with more aggressive tax incentives.3
Compliance and Documentation: Protecting the Allocated Credit
Any “allocation” of the Minnesota R&D credit is subject to intense scrutiny during state audits. Because the credit is “non-conforming” in several key areas—most notably the geographic restriction and the base amount calculation—taxpayers must maintain a higher standard of documentation than is required for the federal credit alone.4
The Substantiation Burden
The Minnesota Department of Revenue provides specific guidance on the records necessary to support the calculation and allocation of the credit.4 If a taxpayer “allocates” a credit to a group member or a shareholder, they must be prepared to provide:
- Proof of Minnesota Nexus: Documentation proving that the research activities were performed in Minnesota. This includes lab addresses, employee residence records, and project logs that tie specific tasks to Minnesota locations.4
- The Four-Part Test Documentation: Project descriptions that detail the technical uncertainty, the process of experimentation, and the technological nature of the research.4
- Wage and Time Records: For internal research, taxpayers must maintain records showing the specific time each employee dedicated to qualified activities. This is often achieved through contemporaneous time-tracking software or detailed quarterly interviews.4
- Supply Invoices and Project Ties: Records of physical supplies used in the research process, with a clear link to the specific projects they supported.4
- Contract Research Agreements: Contracts with third-party researchers that specify the scope of work, the location of the research (must be in Minnesota), and the payment terms.4
Common Audit Pitfalls in Allocation
Auditors frequently challenge the “allocation” of expenses that may have a dual purpose or are conducted across state lines.4 For instance, a software developer who works remotely from a cabin in Wisconsin for three months of the year cannot have their wages for that period “allocated” toward the Minnesota R&D credit, even if the company is based in Minneapolis.4 Similarly, “adaptation” of an existing product or “market research” is explicitly excluded from the definition of qualified research and must be carved out of the allocation pool.4
The Department of Revenue also scrutinizes the “allocation” of gross receipts used in the base amount calculation.1 Following the General Mills decision, errors in distinguishing between Minnesota sales and federal gross receipts in the denominator of the fixed-base percentage can lead to the total disqualification of the credit.12
Conclusion: Strategic Integration of Credit Allocation
Allocating the credit within the Minnesota Research and Development tax credit framework is far more than a clerical exercise in tax preparation; it is a vital strategic function for any innovative business operating in the state.2 For pass-through entities, it provides a direct mechanism to incentivize owners and partners by flowing the benefits of research directly to their individual returns.2 For unitary corporate groups, the ability to share both current-year credits and carryforwards—a right clearly established by the 2020 MDOR guidance—ensures that the group’s innovation is rewarded regardless of its internal corporate architecture.2
As the state moves into the era of partial refundability in 2025, the stakes for accurate and aggressive allocation planning have never been higher.11 The introduction of a cash-refund option provides a transformative opportunity for startups and distressed firms to monetize their innovation immediately, rather than waiting for future profitability.11 However, this new flexibility comes with increased complexity in elections and calculations that demand expert-level precision.4
Ultimately, the successful utilization of the Minnesota R&D credit depends on a taxpayer’s ability to navigate the intersection of state statutes, federal definitions, and evolving administrative guidance.1 By mastering the nuances of “allocating the credit,” Minnesota businesses can ensure that their investments in technology and science are fully protected and optimized, providing the fiscal fuel necessary to drive the next generation of Minnesota-born innovation.
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state










